This opportunity is no longer accepting applications.
grant PAR-21-355

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

This grant opportunity supports research focused on developing new screening methods and treatments for severe conditions identified through newborn screening, as well as genetic conditions that may soon be eligible for screening. The aim is to create accurate tests and prove the benefits of early intervention. It targets "high priority" conditions, which are not yet on newborn screening panel…

This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic conditions where screening may be poss…

Funding Source

Agency: National Institutes of Health
Sub-agency: <em>Eunice Kennedy Shriver</em> National Institute of Child Health and Human Development
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Submission Deadline: November 16, 2024
Opportunity Released: November 9, 2021
Open for Submission: November 9, 2021
Application Window Closes: November 16, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.